Ying L

No ORCID on file · 4 papers in corpus · active 2016-2026

Study types

  • article 1
  • other 1

Condition tags

  • endometriosis 2
other 2026
A multi-dimensional computational screening strategy for rapid identification of active components from traditional chinese medicine: Validation and application in Liangdi decoction against endometriosis
Computational biology and chemistry ·doi:10.1016/j.compbiolchem.2026.109118

AIMS: This study aims to develop and validate a Multi-Dimensional Computational Screening (MDCS) strategy to identify bioactive components by jointly considering target affinity, exposure potential, and safety, using Liangdi decoction (LDD)…

article 2025
Upregulation of miR-183 inhibits the invasion and migration of endometrial stromal cells in endometriosis patients by downregulating Ezrin
Frontiers in oncology ·doi:10.3389/fonc.2025.1537528

PURPOSE: The present study investigated the expression and role of miR-183 in the proliferation, invasion, migration, and apoptosis of endometrial stromal cells in endometriosis patients and the potential involvement of targeting Ezrin. ME…

2023
Hysteroscopic hysteroplasty for the treatment of T-shaped uteri in women with reproductive failure.
Frontiers in medicine ·doi:10.3389/fmed.2023.1269733

ObjectiveTo evaluate the efficacy of hysteroscopic hysteroplasty in the treatment of uterine malformation complicated by primary reproductive disorders.MethodsWomen with unexplained primary infertility, repeated in vitro fertilization (IVF)…

2016
Complement component 7 (C7), a potential tumor suppressor, is correlated with tumor progression and prognosis.
Oncotarget ·doi:10.18632/oncotarget.13294

Our previous study found copy number variation of chromosome fragment 5p13.1-13.3 might involve in the progression of ovarian cancer. In the current study, the alteration was validated and complement component 7 (C7), located on 5p13.1, was…